ESTA vs. AVNS, ZJYL, INGN, ENOV, EWTX, LMAT, MORF, AVDL, DVAX, and AGIO
Should you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Avanos Medical (AVNS), Jin Medical International (ZJYL), Inogen (INGN), Enovis (ENOV), Edgewise Therapeutics (EWTX), LeMaitre Vascular (LMAT), Morphic (MORF), Avadel Pharmaceuticals (AVDL), Dynavax Technologies (DVAX), and Agios Pharmaceuticals (AGIO). These companies are all part of the "medical" sector.
Establishment Labs (NASDAQ:ESTA) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings, profitability and community ranking.
Establishment Labs received 30 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 62.22% of users gave Establishment Labs an outperform vote while only 55.41% of users gave Avanos Medical an outperform vote.
Establishment Labs currently has a consensus target price of $63.33, suggesting a potential upside of 21.61%. Avanos Medical has a consensus target price of $31.00, suggesting a potential upside of 66.58%. Given Avanos Medical's higher probable upside, analysts clearly believe Avanos Medical is more favorable than Establishment Labs.
72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 12.6% of Establishment Labs shares are owned by company insiders. Comparatively, 3.9% of Avanos Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Establishment Labs has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.
In the previous week, Establishment Labs had 7 more articles in the media than Avanos Medical. MarketBeat recorded 8 mentions for Establishment Labs and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.00 beat Establishment Labs' score of 0.50 indicating that Avanos Medical is being referred to more favorably in the news media.
Avanos Medical has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.
Avanos Medical has a net margin of -8.76% compared to Establishment Labs' net margin of -47.53%. Avanos Medical's return on equity of 4.25% beat Establishment Labs' return on equity.
Summary
Avanos Medical beats Establishment Labs on 10 of the 18 factors compared between the two stocks.
Get Establishment Labs News Delivered to You Automatically
Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Establishment Labs Competitors List
Related Companies and Tools
